Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000929624-00-000233
Filing Date
2000-02-16
Accepted
2000-02-16 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13-D (WEI-CHEN LEE) SC 13D 10478
  Complete submission text file 0000929624-00-000233.txt   12469
Mailing Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110
Business Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110 4089882500
CELTRIX PHARMACEUTICALS INC (Subject) CIK: 0000871395 (see all company filings)

EIN.: 943121462 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-41502 | Film No.: 546732
SIC: 2834 Pharmaceutical Preparations

Mailing Address 172 BANKING EAST ROAD SECTION 2, TAIWAN REPUBLIC OF CHINA 104
Business Address 172 BANKING EAST ROAD SECTION 2, TAIWAN REPUBLIC OF CHINA 104
LEE WEI-CHEN (Filed by) CIK: 0001106855 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231